Curis
CRIS
#10277
Rank
HK$0.18 B
Marketcap
HK$4.64
Share price
-1.33%
Change (1 day)
-75.87%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -HK$28.58

According to Curis's latest financial reports the company's current EPS (TTM) is -HK$28.75. In 2024 the company made an earnings per share (EPS) of -HK$55.08 an increase over its 2023 EPS that were of -HK$70.74.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$28.58-48.11%
2024-HK$55.08-22.15%
2023-HK$70.74-26.17%
2022-HK$95.8122.3%
2021-HK$78.34-25.37%
2020-HK$104.98-30.93%
2019-HK$151.99-2.02%
2018-HK$155.12
2016-HK$352.54-10%
2015-HK$391.72138.1%
2014-HK$164.5240%
2013-HK$117.51-25%
2012-HK$156.6966.67%
2011-HK$94.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$10.65-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.11-194.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.82-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$22.64-178.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$30.48 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$88.06 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$11.05-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA